These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15540545)

  • 1. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F
    MMW Fortschr Med; 2004 Sep; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract]   [Full Text] [Related]  

  • 2. Back to basics. Cholesterol.
    Roberts SS
    Diabetes Forecast; 2005 Mar; 58(3):33-5. PubMed ID: 15806692
    [No Abstract]   [Full Text] [Related]  

  • 3. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 4. NCEP's new guidelines at a glance. National Cholesterol Education Program.
    Benedict M
    Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
    Parhofer KG
    MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
    [No Abstract]   [Full Text] [Related]  

  • 6. High blood cholesterol.
    National Heart, Lung and Blood Institute
    Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CME-Lab 2/Solution. Hypercholesteremia and therapy control].
    von Eckardstein A
    Praxis (Bern 1994); 2007 Apr; 96(17):701-2. PubMed ID: 17491201
    [No Abstract]   [Full Text] [Related]  

  • 8. Diet, alcohol consumption, smoking and exercise as determinants of blood lipid levels of Nigerians.
    Adedeji OO
    West Afr J Med; 2000; 19(4):283-5. PubMed ID: 11391842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

  • 10. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular risk factors in supersonic pilots in Poland.
    Mazurek K; Wielgosz A; Efenberg B; Orzel A
    Aviat Space Environ Med; 2000 Dec; 71(12):1202-5. PubMed ID: 11439719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholesterol: how and when to treat it?].
    Masana Marín L
    Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. At age 62 I'm a bit overweight and have diabetes. I take a statin, and my LDL cholesterol is good (84 mg/dL). But my HDL is low (30 mg/dL) and my triglycerides are above 300 mg/dL. Are high triglycerides a problem?
    Lee TH
    Harv Heart Lett; 2003 Mar; 13(7):8. PubMed ID: 12654588
    [No Abstract]   [Full Text] [Related]  

  • 14. Your cholesterol might have to come down--way down.
    Comarow A
    US News World Rep; 2001 May; 130(21):46-8. PubMed ID: 11383131
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical steps for targeting heart disease's biggest villain.
    Clin Resour Manag; 2001 Dec; 2(12):190-1, 177. PubMed ID: 11794829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins, life style and treatment of hypercholesterolemia: the time is changing, criteria too].
    Pintó X
    Med Clin (Barc); 2006 Feb; 126(6):217-9. PubMed ID: 16510095
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of lipid disorders.
    Zarowitz BJ; Aronow WS; Hollenack K; O'Shea T
    Geriatr Nurs; 2006; 27(3):142-8. PubMed ID: 16757384
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.